Biotech M&A – 2021 Deals

Biotech M&A – 2021 Deals

Biotech M&A With a Slow Start in 2020: More Deals to Follow?

DateAcquirer Co.Acquirer TickerAcquired Co.Acquired TickerDeal valuePrice/ShareNotesLink to the news PR
01/05/2021Hologic, Inc.HOLXSOMATEX Private-German co.$64M-leader in biopsy site markershttps://bwnews.pr/2L3d7lF
01/07/2021 PerkinElmerPKI Oxford Immunotec OXFD $591M $22 infectious disease testing https://bwnews.pr/3ovVucz
01/08/2021ChimerixCMRXOncoceutics, Inc.Private co.$78M-Recurrent H3 K27M-mutant Gliomahttps://bit.ly/39f02O9
02/01/2021Horizon TherapeuticsHZNPViela BioVIE$3.05B$53commercial rare disease medicine portfolio with UPLIZNAhttps://bwnews.pr/36vLEQS
02/03/2021Jazz Pharmaceuticals JAZZGW PharmaceuticalsGWPH$7.2B$$220Cannabidiol - Epidiolex
$200 in cash & $20 in Jazz shares
https://prn.to/3cHtijN
02/23/2021Beam TherapeuticsBEAMGuide TherapeuticsPrivate co.$120M in BEAM stockslipid nanoparticle (LNP)https://bit.ly/3urizAI
02/25/2021MerckMRKPandion TherapeuticsPAND$1.85B$60IL-2 & Autoimmunehttps://bwnews.pr/3bDZJO7
03/03/2021AmgenAMGNFive Prime TherapeuticsFPRX$1.9B$38Bemarituzumab, Ph3 for Gastric Cancerhttps://prn.to/3qpRPNF

For M&A 2020 full table click here https://www.chimeraresearchgroup.com/biotech-ma-2020-deals/

Recent Press

Slider

Log In

JoinLost Password?